General form of registration statement for all companies including face-amount certificate companies

Equity Compensation Plan (Details Narrative)

v3.22.0.1
Equity Compensation Plan (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
Mar. 11, 2020
Nov. 05, 2019
Jun. 22, 2021
Sep. 22, 2020
Jul. 16, 2020
Mar. 26, 2020
Sep. 25, 2019
Jun. 18, 2019
Sep. 30, 2021
Jun. 30, 2021
Mar. 31, 2021
Sep. 30, 2020
Jun. 30, 2020
Mar. 31, 2020
Sep. 30, 2021
Sep. 30, 2020
Dec. 31, 2020
Dec. 31, 2019
Sep. 25, 2021
Sep. 22, 2021
Sep. 16, 2020
Sep. 15, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                            
Stock-based compensation expense                 $ 221,000     $ 180,000     $ 1,123,000 $ 329,000            
General and administrative expenses                 192,000     101,000     1,023,000 198,000            
Research and development expenses                 27,000     36,000     69,000 70,000            
Cost of revenues                 2,000     43,000     31,000 $ 61,000 $ 1,453,005 $ 589,640        
Unamortized stock-based compensation                 1,300,000           $ 1,300,000   $ 3,300,000          
Unamortized stock-based compensation period                             1 year 8 months 12 days              
Intrinsic value of outstanding                 547,000           $ 547,000              
Intrinsic value of vested stock options                 413,000           $ 413,000              
Weighted average grant date fair value                                 $ 1.20 $ 0.93        
Stock-based compensation expense               $ 524,650 $ 221,350 $ 223,155 $ 678,918 $ 148,781 $ 116,613 $ 63,880     $ 623,457 $ 62,099        
General and Administrative Expense [Member]                                            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                            
Stock-based compensation expense                                 420,000 47,000        
Research and Development Expense [Member]                                            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                            
Stock-based compensation expense                                 67,000 9,000        
Deferred Costs [Member]                                            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                            
Stock-based compensation expense                                 13,000 $ 7,000        
Cost of Sales [Member]                                            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                            
Stock-based compensation expense                                 $ 123,000          
Chief Executive Officer [Member]                                            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                            
Unvested options                                     25,000 1,911,160    
Options Held [Member]                                            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                            
Option granted     388,246                                      
Equity Compensation Plan description The grant was reduced to 500,000 options, including 375,000 options and 125,000 options respectively under the two categories, due to limitations under the 2019 Plan. The terms of the 125,000 performance-based options were established in the quarter ended September 30, 2020. The terms of the performance-based options were met during the quarter ended March 31, 2021         Board of Directors and a majority of the Company’s shareholders approved an amendment to the 2019 Plan to (i) increase the number of shares of Common Stock authorized for issuance under the 2019 Plan by 1,174,000 shares, such that a total of 2,500,000 shares of Common Stock are now authorized for issuance under the 2019 Plan; (ii) increase the maximum aggregate number of shares, options and/or other awards that may be granted to any one person during any calendar year from 500,000 to 1,300,000; and (iii) clarify the availability of cashless exercise as a form of consideration                                
Options Held [Member] | Minimum [Member]                                            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                            
Option grant term     2 years                                      
Option exercise price     $ 2.90                                      
Options Held [Member] | Maximum [Member]                                            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                            
Option grant term     5 years                                      
Option exercise price     $ 3.93                                      
Options Held [Member] | Executive Chairman [Member]                                            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                            
Option granted 965,850       600,000                                  
Option grant term 2 years       10 years                                  
Option exercise price         $ 1.50                                  
Options Held [Member] | Chief Executive Officer [Member]                                            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                            
Option granted 321,950     1,637,410 200,000                                  
Option grant term 10 years     2 years 1 year                                  
Option exercise price $ 1.50     $ 1.50                                    
Options Held [Member] | Non-employee directors                                            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                            
Option granted             350,000                              
Option grant term             10 years                              
Option exercise price             $ 1.50                              
Options Held [Member] | Employees                                            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                            
Option granted   240,000                                        
Option grant term   5 years                                        
Option exercise price   $ 1.50                                        
N 2019 Equity Compensation Plan [Member]                                            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                            
Number of Shares Authorized               1,326,000                         4,600,000  
Amended N 2019 Equity Compensation Plan [Member]                                            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                            
Number of Shares Authorized                                         4,600,000 2,500,000